Improving Medication Therapy Through a Digital Interdisciplinary Medicine Therapy Optimisation Model
MTO
Improving Medication Therapy and Patient Involvement Through a Digital Interdisciplinary Model Among Old People in Primary Care Living in Sparsely Populated Regions in Sweden
1 other identifier
interventional
100
1 country
2
Brief Summary
In this study, a telepharmacy service in primary care for home-living older adults in Northern Sweden's rural areas will be developed and evaluated. The primary objective is to evaluate the effect of the service regarding the identification, classification, and resolution of medication-related problems (MRPs). Secondary objectives are to evaluate participants' medication adherence, health-related quality of life, and beliefs about medicines through self-report questionnaires. The telepharmacy service include medication interviews, structured medication reviews, interdisciplinary patient-centred discussions, and follow-ups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2022
CompletedFirst Posted
Study publicly available on registry
November 29, 2022
CompletedStudy Start
First participant enrolled
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
May 5, 2026
April 1, 2026
4 years
November 7, 2022
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Identification and classfication of medication-related problems
Classification of mediation-related problems according to a modified version of the classification system by Cipolle et al (1998).
The 12-week intervention period
Resolution of medication-related problems
The clinical pharmacists' recommendations to resolve medication-related problems will be classified according to a modified version of a system developed by the French Society of Clinical pharmacy. Physicians' acceptance rate of pharmacists' recommendations will be classified. The acceptance rate will be classified as accepted recommendation, rejected recommendation, or unknown.
12-week intervention period
Intra-individual change in self-reported medication adherence: Medication Adherence Report Scale-5 (MARS-5)
Assessing self-reported medication adherence through the MARS-5 questionnaire. Total score ranging between 5 and 25, with higher scores indicating a higher level of medication adherence.
Baseline and 12 weeks
Intra-individual change in self-reported health-related quality of life: EuroQol-5 Dimension-5 Level questionnaire (EQ-5D-5L)
Assessing health-related quality of life through the EQ-5D-5L-questionnaire. The questionnaire consists of five questions regarding self-perceived quality of life, and a visual analogue scale on which the respondents evaluate their own health status on a scale of 0-100.
Baseline and 12 weeks
Intra-individual change in self-reported beliefs about medicines: The Beliefs about Medicines Questionnaire (BMQ)
Assessing beliefs about medicines through the BMQ. The questionnaire consists of two different scales; BMQ-General assesses the respondent's beliefs about medicines in general and BMQ-Specific evaluates the individual's beliefs about medicines prescribed for their own use.
Baseline and 12 weeks
Study Arms (1)
Digital intervention
OTHERVideo-based telepharmacy service
Interventions
Video-based medication interviews, structured medication reviews, interdisciplinary patient-centred discussions, follow-ups
Eligibility Criteria
You may qualify if:
- Using five or more prescribed medications and/or considered as a potential candidate by the primary care physician.
- Living at home (i.e not in a nursing home)
- Registered at primary healthcare centres in rural municipalities within Västerbotten County (and neighbouring counties if necessary)
You may not qualify if:
- Do not speak Swedish
- Unable to communicate
- Has a confirmed major neurocognitive disorder
- Receives palliative care
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Västerbottencollaborator
- Umeå Universitylead
Study Sites (2)
Åsele healthcare centre
Åsele, Sweden
Storuman healthcare centre
Storuman, Sweden
Related Publications (1)
Westberg A, Andersson P, Sonnerstam E, Mattsson S, Holmner A, Edin-Liljegren A, Gustafsson M. Development and evaluation of a telepharmacy service in primary care for home-living older adults in Northern Sweden's rural areas: protocol for a single-arm interventional study. BMJ Open. 2025 Nov 19;15(11):e110198. doi: 10.1136/bmjopen-2025-110198.
PMID: 41263936DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Maria Gustafsson, Ph.D
Department of Medical and Translational Biology, Umeå University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 7, 2022
First Posted
November 29, 2022
Study Start
November 22, 2023
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared or publicly available due to privacy and ethical restrictions.